Becton Dickinson (STU:BOX) FFO


STU:BOX Becton Dickinson & Co STU:BOX
78 GF Score
Price €132.95
GF Value €164.35
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson FFO?

FFO (Funds from operations) only applies to REITs.

STU:BOX
78GF Score
Becton Dickinson & Co STU:BOX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Becton Dickinson (STU:BOX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of €132.95 is trading 19.1% below its estimated GF Value™ of €164.35. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for STU:BOX:

  • FFO:
  • GF Value™: €164.35 vs. price of €132.95 (19.1% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the STU:BOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
78GF Score

Get the complete analysis for STU:BOX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€132.95
Price
€164.35
GF Value